🔍 Observations
Topline
- Revenue from operations grew 16.2% YoY (₹23,76,875L → ₹27,61,011L), with Q4FY26 alone at ₹10,22,443L — a 11.8% beat over Q4FY25’s ₹9,14,959L, confirming back-half loading.
- Sequential Q4 surge (₹7,15,385L in Q3 → ₹10,22,443L) reflects typical defence order execution bunching in year-end quarter.
- Other income declined sharply YoY (₹74,236L → ₹56,603L), pulling total income growth slightly below revenue growth at 14.9%.
Bottomline
- Net profit grew 13.9% YoY (₹5,32,268L → ₹6,06,226L); Q4FY26 PAT of ₹2,22,635L surpassed Q4FY25’s ₹2,12,702L by 4.7%.
- Effective tax rate eased to 25.2% vs 25.5% in FY25, aided by deferred tax credit of ₹3,491L (vs ₹4,150L charge in FY25) — meaningful swing.
- EPS rose from ₹7.28 to ₹8.29 (+13.9%), fully diluted, on unchanged share capital.
Margins
- EBIT (PBT ex-other income, ex-finance cost): ₹27,61,011L revenue vs PBT ₹8,05,296L less other income ₹56,603L plus finance cost ₹673L = operating profit ₹7,49,366L → EBIT margin ~27.1% vs prior year: ₹7,09,900L – ₹74,236L + ₹968L = ₹6,36,632L on ₹23,76,875L → 26.8%. Marginal expansion of ~30 bps.
- Net profit margin: ₹6,06,226L ÷ ₹27,61,011L = 21.96% vs ₹5,32,268L ÷ ₹23,76,875L = 22.39% — slight 43 bps compression, driven by faster opex growth.
- Employee costs grew faster than revenue (12.9% → ₹3,11,555L); other expenses jumped 21.4% (₹1,98,719L → ₹2,41,208L), indicating cost base expanding ahead of topline.
Growth Trajectory
- 16.2% revenue CAGR (1-year) on a large base signals continued defence capex tailwinds; order book execution is accelerating.
- PAT growth lagging revenue growth (13.9% vs 16.2%) — margin dilution risk if opex inflation persists.
- Q4 concentration (~37% of FY revenue) remains a structural feature; execution risk is high if year-end order flows are delayed.

🧮 Profit & Loss Statement

🧮 Balance Sheet

🧮 Cash Flows Statement

🟢 Green Flags
- Zero debt balance sheet — no borrowings (current or non-current), making BEL immune to rate cycle risks and freeing all cash flows for reinvestment or payout.
- Cash + bank balances surged to ₹8,57,203L (₹1,88,796L cash + ₹6,68,407L deposits) vs ₹9,54,510L prior year — still fortress-level liquidity despite higher dividend outflow.
- Operating cash flow nearly tripled YoY (₹56,427L → ₹1,54,137L), validating that earnings quality is improving, not just headline profits.
- Consistent dividend payout — financing outflow of ₹2,08,289L in dividends (vs ₹1,68,078L) reflects 24% increase in payout, shareholder-friendly capital allocation.
- Intangible assets activated — other intangibles jumped from ₹21,466L to ₹63,903L, indicating capitalisation of R&D/technology investments that will drive future IP-led revenue.
- Trade payables held stable relative to scale — no aggressive creditor stretching, supplier relationships intact.
- Equity base strengthened — total equity rose 20.1% (₹19,99,283L → ₹24,00,714L), driven by retained earnings compounding.
🔴 Red Flags
- Trade receivables spike — jumped 41.2% (₹9,11,637L → ₹12,87,576L), far outpacing revenue growth of 16.2%; signals slower collections or aggressive year-end billing.
- Other current liabilities contracted — fell from ₹14,28,702L to ₹13,22,105L, implying advance drawdowns from customers are slowing — a leading indicator of order momentum softness.
- Inventory build — current inventories rose ₹1,05,655L (₹9,11,898L → ₹10,17,553L), tying up working capital in a capital-intensive cycle.
- Free cash flow thin relative to PAT — capex of ₹98,536L against operating CF of ₹1,54,137L yields FCF of ~₹55,601L vs PAT of ₹6,06,226L; FCF conversion is only ~9.2%, well below earnings quality threshold.
- Other expenses inflation — 21.4% growth in other expenses (₹1,98,719L → ₹2,41,208L) with no segment disclosure makes it impossible to identify if this is structural or one-time.
- Other income declining — fell from ₹74,236L to ₹56,603L (-23.8%); as interest income normalises, this cushion shrinks and EBIT quality becomes more important.
📊 Balance Sheet Analysis
- Asset quality: strong — non-current assets clean (no goodwill, no impairments flagged); intangibles rising but tied to active development programmes.
- Liquidity: robust — current ratio estimated at ₹38,05,687L ÷ ₹19,25,975L = 1.98x; comfortable cover, though receivables inflation warrants monitoring.
- Leverage: nil — zero financial debt across both years; lease liabilities of ₹6,546L are negligible. Net cash position is a structural advantage.
- Working capital deteriorating — net working capital (current assets less current liabilities) expanded from ₹15,10,534L to ₹18,79,712L (+₹3,69,178L), driven by receivables and inventory build; capital efficiency is declining.
💰 Cash Flow Analysis
- Operating CF of ₹1,54,137L (vs ₹56,427L) reflects improved collections and lower advance reversals — but working capital consumed ₹4,79,942L in aggregate, limiting conversion.
- Investing CF positive at ₹1,73,000L — largely from unwinding of term deposits (₹2,14,639L inflow), not asset monetisation; capex remained disciplined at ₹98,536L.
- Financing CF outflow of ₹2,09,686L entirely dividend-driven — clean capital structure with no debt service drag.
- Net cash position improved by ₹1,17,451L — healthy, but the quality of this improvement depends on whether receivables of ₹12,87,576L convert in H1FY27.
💡 Investment Outlook
BEL delivered solid FY26 growth — 16.2% revenue and 13.9% PAT expansion — underpinned by a debt-free balance sheet and improving operating cash flows, confirming the defence capex supercycle is translating into real earnings.
The margin re-rating story, however, remains incomplete: net margins compressed 43 bps, opex is outpacing revenue, and FCF conversion at ~9% is too thin for a business of this quality.
The key watchpoint for FY27 is receivables resolution — if the ₹12,87,576L receivable book does not normalise, working capital drag will pressure both FCF and return ratios.
Investors should track advance-to-revenue ratio and other current liabilities trajectory as the earliest signal of order momentum sustaining into the next cycle.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.